Access denied
You are not authorized to access this page.
Project |
Location(s) |
Topics |
Start |
End |
Epidemiology and Pathogenesis of Pulmonary Hypertension in HIV Patients |
United States |
HIV/AIDS, Epidemiology and Surveillance |
|
|
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection |
United States |
HIV/AIDS, Cardiovascular Disease, Pharmacology and Drug Treatment |
|
|
Effect of low dose methotrexate on endothelial function and inflammation in HIV |
United States |
HIV/AIDS, Cardiovascular Disease |
|
|
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV |
United States |
HIV/AIDS |
|
|
HIV Viral Reservoirs and Monocyte Activation in HIV-Associated Atherosclerosis |
United States |
HIV/AIDS, Cardiovascular Disease |
|
|
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV |
United States |
HIV/AIDS, Cardiovascular Disease |
|
|
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV |
United States |
HIV/AIDS, Immunology |
|
|
Randomized, Double-Blind Placebo-Controlled Phase 2a Study to Assess the Effect of CCR2 Antagonism by MLN1202 on Atherosclerotic Inflammation in Subjects with Stable Atherosclerotic Cardiovascular Disease Using FDG PET/CT Imaging |
United States |
Cardiovascular Disease |
|
|
Effect of low dose methotrexate on endothelial function and inflammation in HIV |
United States |
HIV/AIDS, Cardiovascular Disease |
|
|
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans |
United States |
HIV/AIDS, Cardiovascular Disease |
|
|
Cardiovascular Inflammation Reduction Trial (CIRT) |
United States |
Cardiovascular Disease |
|
|
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) |
United States |
HIV/AIDS, Cardiovascular Disease, Aging |
|
|